FDA Approves Pfizer’s VELSIPITY  (etr
Velsipity (etrasimod) is an oral, once-daily, 2mg dose medication for adults with moderately to severely
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Velsipity (etrasimod) is an oral, once-daily, 2mg dose medication for adults with moderately to severely
Fabre-Kramer Pharmaceuticals Inc. (Fabre-Kramer), a biopharmaceutical company announced approval of Exxuaâ„¢ (gepirone hydrochloride extended-release tablets)
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical
</a> Marketing Authorisation on the request of MA holder Guidehouse Germany GmbH)
USFDA has granted full approval for Pfizers Paxlovid, first Oral antiviral for COVID; This is
FDA has approved Xacduro injection (Durlobactam, a new molecular entity in combination with sulbactam) for